Orange Book product · Generic (ANDA)
ZOLMITRIPTAN
ZOLMITRIPTAN
At a glance
Sep 30, 2021
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 30, 2021
4 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
ZOLMITRIPTAN
Strength
2.5MG/SPRAY
Dosage form
SPRAY
Route
NASAL
TE code
AB
Application
ANDA 212469
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ZOLMITRIPTAN
- 2013ZOMIGBrand (NDA)
NDA 021450 · AMNEAL
- 2001ZOMIG-ZMTBrand (NDA)
NDA 021231 · ASTRAZENECA
- 1997ZOMIGBrand (NDA)
NDA 020768 · IPR
- 2019ZOLMITRIPTANGeneric (ANDA)
ANDA 203726 · ORBION PHARMS
- 2019ZOLMITRIPTANGeneric (ANDA)
ANDA 202855 · RISING
- 2018ZOLMITRIPTANGeneric (ANDA)
ANDA 203019 · ZYDUS PHARMS
- 2017ZOLMITRIPTANGeneric (ANDA)
ANDA 206973 · CHARTWELL RX
- 2017ZOLMITRIPTANGeneric (ANDA)
ANDA 207867 · PLD ACQUISITIONS LLC
- 2016ZOLMITRIPTANGeneric (ANDA)
ANDA 205074 · ALEMBIC
- 2016ZOLMITRIPTANGeneric (ANDA)
ANDA 204041 · AJANTA PHARMA LTD
- 2016ZOLMITRIPTANGeneric (ANDA)
ANDA 207021 · AUROBINDO PHARMA
- 2015ZOLMITRIPTANGeneric (ANDA)
ANDA 204336 · MACLEODS PHARMS LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
